Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry

Preprocedural anemia in females undergoing transcatheter aortic valve implantation: Insights from the WIN‐TAVI registry

Objectives To assess the impact of anemia on clinical outcomes in female patients enrolled in the Women's InterNational transcatheter aortic valve implantation (WIN‐TAVI) registry. Background Anemia is highly prevalent among females who constitute half of TAVI candidates, yet, its clinical sign...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Catheterization and cardiovascular interventions 2021-04, Vol.97 (5), p.E704-E715
Hauptverfasser: Nicolas, Johny, Claessen, Bimmer E., Cao, Davide, Sartori, Samantha, Baber, Usman, Power, David, Chiarito, Mauro, Goel, Ridhima, Roumeliotis, Anastasios, Chandiramani, Rishi, Chen, Siyan, Chandrasekhar, Jaya, Tchetche, Didier, Petronio, Anna Sonia, Mehilli, Julinda, Lefèvre, Thierry, Presbitero, Patrizia, Capranzano, Piera, Iadanza, Alessandro, Sardella, Gennaro, Van Mieghem, Nicolas M, Meliga, Emanuele, Dumonteil, Nicolas, Fraccaro, Chiara, Trabattoni, Daniela, Mikhail, Ghada, Ferrer‐Gracia, Maria‐Cruz, Naber, Christoph, Sharma, Samin, Morice, Marie‐Claude, Dangas, George D., Chieffo, Alaide, Mehran, Roxana
Format: Artikel
Sprache:eng
Schlagworte:
Anemia
Aortic valve
Cardiovascular diseases
Cerebral infarction
Congestive heart failure
female
Females
Hemoglobin
Mortality
Myocardial infarction
Risk factors
TAVI
TAVR
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objectives To assess the impact of anemia on clinical outcomes in female patients enrolled in the Women's InterNational transcatheter aortic valve implantation (WIN‐TAVI) registry. Background Anemia is highly prevalent among females who constitute half of TAVI candidates, yet, its clinical significance remains poorly investigated. Methods Patients were divided into three groups according to preprocedural hemoglobin (Hb) level: (1) no anemia (Hb ≥12 g/dl), (2) mild‐to‐moderate anemia (10 ≤ Hb
ISSN:1522-1946
1522-726X
DOI:10.1002/ccd.29276